{
    "organizations": [],
    "uuid": "77d32f028a4be59b6888ead32a70587a9ff5723a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eleven-biotherapeutics-reports-q4/brief-eleven-biotherapeutics-reports-q4-loss-per-share-0-22-idUSASC09UY6",
    "ord_in_thread": 0,
    "title": "BRIEF-Eleven Biotherapeutics Reports Q4 Loss Per Share $0.22",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 4 (Reuters) - Eleven Biotherapeutics Inc:\n* ELEVEN BIOTHERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 OPERATING RESULTS AND VICINIUM DEVELOPMENT PROGRESS\n* Q4 LOSS PER SHARE $0.22 * ELEVEN BIOTHERAPEUTICS - NO REV WAS RECOGNIZED DURING QTR ENDED DEC. 31, 2017 VS $0.8 MLN FOR SAME THREE-MONTH PERIOD IN 2016\n* ELEVEN BIOTHERAPEUTICS INC - EXPECTS TO HAVE CAPITAL TO FUND CURRENT OPERATING PLANS INTO Q1 2019\n* ELEVEN BIOTHERAPEUTICS INC - CASH AND CASH EQUIVALENTS WERE $14.7 MILLION AS OF DECEMBER 31, 2017 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-05T04:26:00.000+03:00",
    "crawled": "2018-04-05T17:24:57.013+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "eleven",
        "biotherapeutics",
        "inc",
        "eleven",
        "biotherapeutics",
        "report",
        "fourth",
        "quarter",
        "operating",
        "result",
        "vicinium",
        "development",
        "progress",
        "q4",
        "loss",
        "per",
        "share",
        "eleven",
        "biotherapeutics",
        "rev",
        "recognized",
        "qtr",
        "ended",
        "v",
        "mln",
        "period",
        "eleven",
        "biotherapeutics",
        "inc",
        "expects",
        "capital",
        "fund",
        "current",
        "operating",
        "plan",
        "q1",
        "eleven",
        "biotherapeutics",
        "inc",
        "cash",
        "cash",
        "equivalent",
        "million",
        "december",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}